Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal L24 domain containing 1 pseudogene 9 (RSL24D1P9) is annotated as a pseudogene, meaning it is a genomic locus with sequence similarity to a protein-coding gene but is generally non-functional in terms of protein coding[5][2][1]. Pseudogenes like RSL24D1P9 are often derived from duplication or retrotransposition events of functional genes—in this case, related to the Ribosomal L24 domain containing 1 (RSL24D1) gene, which is involved in ribosomal large subunit formation[5][1][7]. No robust evidence supports a biological function, disease role, or utility as a therapeutic target for RSL24D1P9[5][1]. As with most pseudogenes, it does not encode a functional protein and is not used as a receptor, enzyme, or other therapeutic target class[5][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal L24 domain containing 1 pseudogene 9 (RSL24D1P9).